fair values of intangible assets, determining, Ch. 9, 5.5.2.F
at initial recognition, Ch. 14, 13.2.1
in-process research or development project expenditure,
initial net investment, Ch. 42, 2.2
Ch. 9, 5.5.2.D
Interest-free long-term loans, Ch. 45, 3.3.1
Multi Period Excess Earnings Method (MEEM), Ch. 9,
Interests in consolidated structured entities
5.5.2.F
disclosure of risks associated with, Ch. 13, 4.4
Relief from Royalty method, Ch. 9, 5.5.2.F
Interests in joint arrangements and associates, disclosure of,
separability, Ch. 9, 5.5.2; Ch. 17, 5.1.3.B
Ch. 13, 5. See also IFRS 12
recognition, Ch. 17, 3.1
extent, Ch. 13, 5.1
PP&E components classified as, Ch. 18, 3.1.4
financial effects, Ch. 13, 5.1
separate acquisition, Ch. 17, 4
individually immaterial joint ventures and associates, Ch. 13,
acquisition by way of government grant, Ch. 17, 4.6
5.1.2
components of cost, Ch. 17, 4.2
joint ventures, Ch. 13, 5.2
costs to be expensed, Ch. 17, 4.3
nature, Ch. 13, 5.1
exchanges of assets, Ch. 17, 4.7
risks associated, Ch. 13, 5.2
commercial substance, Ch. 17, 4.7.2
summarised financial information, Ch. 13, 5.1.1
measurement of assets exchanged, Ch. 17, 4.7.1
Interests in other entities, Ch. 13, 2.2.1.A, 2.2.3.D
income from incidental operations, Ch. 17, 4.4
Interests in subsidiaries, disclosure of, Ch. 13, 4
measurement of intangible assets acquired for contingent
changes in ownership interests in subsidiaries, Ch. 13, 4.5
consideration, Ch. 17, 4.5
composition of the group, Ch. 13, 4.1
recognition, Ch. 17, 4.1
interests of non-controlling interests, Ch. 13, 4.2
subsequent expenditure, Ch. 17, 3.3
of nature and extent of significant restrictions, Ch. 13, 4.3
useful life of, assessing, Ch. 17, 9.1
required by investment entities, Ch. 13, 4.6
with an indefinite useful life, Ch. 17, 9.3
risks associated with interests in consolidated structured
contractual/other legal rights, Ch. 17, 9.1.2
entities, Ch. 13, 4.4
factors affecting, Ch. 17, 9.1.1
terms of contractual arrangements, Ch. 13, 4.4.1
with a finite useful life, Ch. 17, 9.2
Interests in unconsolidated structured entities, disclosure of,
Intellectual property licences, Ch. 28, 9
Ch. 13, 6. See also IFRS 12
identifying performance obligations in a licensing
nature of interests, Ch. 13, 6.1
arrangement, Ch. 28, 9.1
nature, purpose, size, activities and financing of structured
contractual restrictions, Ch. 28, 9.1.3
entities, Ch. 13, 6.1.1
guarantees to defend or maintain a patent, Ch. 28, 9.1.4
sponsored structured entities for which no interest is held
licences of intellectual property that are distinct, Ch. 28,
at the reporting date, Ch. 13, 6.1.2
9.1.1
nature of risks, Ch. 13, 6.2–6.3
licences of intellectual property that are not distinct,
Interim financial reporting, Ch. 37, 1–11. See also IAS 34
Ch. 28, 9.1.2
licence renewals, Ch. 28, 9.4
Interim income tax expense, measuring, Ch. 37, 9.5.1
nature of the entity’s promise in granting a licence,
Internal hedges
determining, Ch. 28, 9.2
held by other group entities, Ch. 49, 4
applying the licensing application guidance to a single
internal hedged items, Ch. 49, 4.3
(bundled) performance obligation that includes a
forecast intragroup transactions, Ch. 49, 4.3.2
licence of intellectual property, Ch. 28, 9.2.1
intragroup monetary items, Ch. 49, 4.3.1
recognising revenue for, Ch. 28, 8.7
internal hedging instruments, Ch. 49, 4.1
sales-based/usage-based royalties on, Ch. 28, 9.5
central clearing parties and ring fencing, Ch. 49, 4.1.1
recognition of royalties for a licence that provides a right to
offsetting instruments, Ch. 49, 4.2
access intellectual property, Ch. 28, 9.5.1
foreign exchange risk, Ch. 49, 4.2.2
transfer of control of licensed intellectual property, Ch. 28, 9.3
interest rate risk, Ch. 49, 4.2.1
178 Index
Internally generated intangible assets, Ch. 17, 6
unpaid interest, royalties, management charges etc., Ch. 29,
brands, Ch. 17, 6.2.4
7.5.6
cost of
unrealised profits and losses in consolidated financial
eligible for capitalisation, Ch. 17, 6.3.2
statements, Ch. 29, 8.7
establishing the time from, Ch. 17, 6.3.1
Intrinsic value method, share-based payments Ch. 30, 8.8.1
customer lists, Ch. 17, 6.2.4
Inventories, Ch. 22, 1–6. See also IAS 2– Inventories
development phase, Ch. 17, 6.2.2
disclosure requirements, Ch. 22, 6
goodwill, Ch. 17, 6.1
interim financial reporting, Ch. 37, 9.4
mastheads, Ch. 17, 6.2.4
measurement, Ch. 22, 3
pharmaceutical industry, research and development in, Ch. 17,
real estate inventory, Ch. 22, 4
6.2.3
recognition in profit/loss, Ch. 22, 5
publishing titles, Ch. 17, 6.2.4
Inventories, extractive industries, Ch. 39, 14
research phase, Ch. 17, 6.2.1
carried at fair value, Ch. 39, 14.4
website costs (SIC-32), Ch. 17, 6.2.5
core inventories, Ch. 39, 14.3
application and infrastructure, Ch. 17, 6.2.5
heap leaching (mining), Ch. 39, 14.6
content development, Ch. 17, 6.2.5
recognition of work in progress, Ch. 39, 14.1
graphical design development, Ch. 17, 6.2.5
sale of by-products and joint products, Ch. 39, 14.2
operating stage, Ch. 17, 6.2.5
by-products, Ch. 39, 14.2.1
planning, Ch. 17, 6.2.5
joint products, Ch. 39, 14.2.2
International Accounting Standards (IAS), Ch. 1, 2.1. See also
stockpiles of low grade ore (mining), Ch. 39, 14.5
individual IAS entries
Investing activities, cash flows, Ch. 36, 4.2
International Accounting Standards Board (IASB), Ch. 1, 2.4.
Investment contracts, Ch. 51, 2.2.2, 3.9.2
See also Conceptual framework, IASB’s
agenda consultation, Ch. 1, 2.4, 3.1
Investment contracts with discretionary participation features,
Annual Improvements Process, Ch. 1, 2.5
Ch. 51, 6.1–6.2, 7.2.2.C; Ch. 52, 11.2
convergence, Ch. 1, 3.2
Investment entity, Ch. 6, 10
current priorities, Ch. 1, 3.1
accounting by a parent of an investment entity, Ch. 6, 10.4
Due Process Handbook, Ch. 1, 2.6
accounting by an investment entity, Ch. 6, 10.3
future agenda, Ch. 1, 3.1
cash flows in, Ch. 36, 6.4.3
maintenance projects, Ch. 3, 6.2
definition, Ch. 6, 10.1
materiality practice statement, Ch. 3, 6.1.2
determining whether an entity is an investment en
tity, Ch. 6,
Monitoring Board, Ch. 1, 2.3
10.2
research projects by, Ch. 3, 6.1–6.3
earnings from investments, Ch. 6, 10.2.3
standard setting structure, Ch. 1, 2.1
exit strategies, Ch. 6, 10.2.2
advisory bodies, Ch. 1, 2.9
fair value measurement, Ch. 6, 10.2.4
IFRS Advisory Council, Ch. 1, 2.7
having more than one investor, Ch. 6, 10.2.6
IFRS Foundation, Ch. 1, 2.2
holding more than one investment, Ch. 6, 10.2.5
IFRS Interpretations Committee, Ch. 1, 2.5–2.6
intermediate holding companies established for tax
standard-setting projects, Ch. 3, 6.1
optimization purposes, Ch. 6, 10.2.1.B
International Financial Reporting Standards (IFRS), Ch. 1, 2.1.
investment entity illustrative examples, Ch. 6, 10.2.9
See also individual IFRS entries
investment-related services, Ch. 6, 10.2.1.A
adoption, worldwide, Ch. 1, 4.1
multi-layered fund structures, Ch. 6, 10.2.10
Americas, Ch. 1, 4.3
ownership interests, Ch. 6, 10.2.8
Asia, Ch. 1, 4.4
unrelated investors, Ch. 6, 10.2.7
Australia, Ch. 1, 4.5
disclosures required by, Ch. 13, 4.6
Europe, Ch. 1, 4.2
Investment property, Ch. 19, 1–13. See also IAS 40
South Africa, Ch. 1, 4.6
cost model, Ch. 19, 7
consistency in application of, Ch. 1, 5
impairment, Ch. 19, 7.3
International Organisation of Securities Commissions (IOSCO),
incidence of use of the cost model, Ch. 19, 7.2
Ch. 1, 1, 2.3, 5
initial recognition, Ch. 19, 7.1
identification of intangible parts, Ch. 19, 7.1.2
Interpretations Committee, Ch. 1, 2.5
identification of tangible parts, Ch. 19, 7.1.1
Intragroup (Intercompany)
definitions, Ch. 19, 2
deferred tax on anticipated intragroup dividends in future
disclosure requirements of IAS 40, Ch. 19, 12
periods, Ch. 29, 7.5.4
additional disclosures for the cost model, Ch. 19, 12.3
eliminations, Ch. 7, 2.4
additional disclosures for the fair value model, Ch. 19,
insurance contracts, Ch. 52, 3.2.2.C
12.2
transactions, Ch. 8, 4.3.1
extra disclosures where fair value cannot be determined
transfer of assets with no change in tax base, Ch. 29, 7.2.5
reliably, Ch. 19, 12.2.2
transfer of tax losses, payments for, Ch. 29, 11.1
presentation of changes in fair value, Ch. 19, 12.2.1
Index
179
disclosures under both fair value and cost models, Ch. 19,
property held under a lease, Ch. 19, 4.5 reclassifications
12.1
from property, plant and equipment (‘PP&E’)/from
disclosure of direct operating expenses, Ch. 19, 12.1.3
inventory, Ch. 19, 4.4
level of aggregation for IFRS 13 disclosures, Ch. 19,
start-up costs and self-built property, Ch. 19, 4.2
12.1.2
interim reporting and IAS 40, Ch. 19, 11
methods and assumptions in fair value estimates,
measurement after initial recognition, Ch. 19, 5
Ch. 19, 12.1.1
by insurers and similar entities, Ch. 19, 5.2
presentation of sales proceeds, Ch. 19, 12.4
property held under an operating lease, Ch. 19, 5.1
disposal of investment property, Ch. 19, 10
recognition, Ch. 19, 3
calculation of gain/loss on disposal, Ch. 19, 10.1
scope, Ch. 19, 2
compensation from third parties, Ch. 19, 10.4
transfer of assets to/from investment property, Ch. 19, 9
replacement of parts of investment property, Ch. 19, 10.3
accounting treatment of transfers, Ch. 19, 9.2
sale prior to completion of construction, Ch. 19, 10.2
transfers from investment property to inventory, Ch. 19, 9.1
fair value model, Ch. 19, 6
transfers of investment property held under operating
deferred taxation for property held by a ‘single asset’ entity,
leases, Ch. 19, 9.3
Ch. 19, 6.10
transfers to or from investment property (IAS 40), Ch. 19, 9
estimating fair value, Ch. 19, 6.1
Investment tax credits, Ch. 25, 2.3.1; Ch. 29, 4.3
comparison with value in use, Ch. 19, 6.1.3
Investments in associates and joint ventures, Ch. 11, 1–11. See
‘double counting,’ Ch. 19, 6.1.4
also Equity method/accounting; IAS 28; Reciprocal interests in
methods of estimation, Ch. 19, 6.1.1
equity accounted entities
observable data, Ch. 19, 6.1.2
application of the equity method, Ch. 11, 7
fair value of investment property under construction,
consistent accounting policies, Ch. 11, 7.8
Ch. 19, 6.3
date of commencement of equity accounting, Ch. 11, 7.3
fixtures and fittings subsumed within fair value, Ch. 19,
discontinuing the use of the equity method, Ch. 11, 7.12
6.5
deemed disposals, Ch. 11, 7.12.5
future capital expenditure and development value (‘highest
investment in associate becomes a joint venture (or
and best use’), Ch. 19, 6.8
vice versa), Ch. 11, 7.12.3
inability to determine fair value of completed investment
investment in associate/joint venture becoming a
property, Ch. 19, 6.2
subsidiary, Ch. 11, 7.12.1
negative present value, Ch. 19, 6.9
partial disposals of interests in associate/joint venture,
prepaid and accrued operating lease income, Ch. 19, 6.6
Ch. 11, 7.12.4
accrued rental income and lease incentives, Ch. 19,
retained investment in the former associate or joint
6.6.1
venture is a financial asset, Ch. 11, 7.12.2
prepaid rental income, Ch. 19, 6.6.2
distributions received in excess of the carrying amount,
transaction costs incurred by the reporting entity on
Ch. 11, 7.10
acquisition, Ch. 19, 6.4
equity accounting and consolidation, comparison between,
valuation adjustment to fair value of properties held under
Ch. 11, 7.2
a lease, Ch. 19, 6.7
equity transactions in an associate’s/joint venture’s
future developments, Ch. 19, 13
financial statements, Ch. 11, 7.11
new leases standard: IFRS 16, Ch. 19, 1.1
dividends/other forms of distributions, Ch. 11, 7.11.1
new standard for insurance contracts, Ch. 19, 13
effects of changes in parent/non-controlling interests in
IFRS 5 and investment property, Ch. 19, 8
subsidiaries, Ch. 11, 7.11.4
initial measurement, Ch. 19, 4
equity-settled share-based payment transactions,
assets acquired in exchange transactions, Ch. 19, 4.6
Ch. 11, 7.11.3
attributable costs, Ch. 19, 4.1
issues of equity instruments, Ch. 11, 7.11.2
acquisition of a group of assets that does not constitute
initial carrying amount of an associate/joint venture,
a business, Ch. 19, 4.1.1
Ch. 11, 7.4
deferred taxes when acquiring a ‘
single asset’ entity that
applying a cost-based approach, Ch. 11, 7.4.2.A
is not a business, Ch. 19, 4.1.2
applying a fair value (IFRS 3) approach, Ch. 11,
borrowing costs, Ch. 19, 4.8
7.4.2.A
contingent costs, Ch. 19, 4.10
following loss of control of an entity, Ch. 7, 3.3.2, 7.1;
deferred payments, Ch. 19, 4.3
Ch. 11, 7.4.1
income from tenanted property during development,
piecemeal acquisition, Ch. 11, 7.4.2
Ch. 19, 4.11
existing associate that becomes a joint venture, or
initial recognition of tenanted investment property
vice versa, Ch. 11, 7.4.2.C
subsequently measured using the cost model, Ch. 19,
financial instrument becoming an associate/joint
4.7
venture, Ch. 11, 7.4.2.A
lease incentives and initial costs of leasing a property,
step increase in an existing associate/joint venture
Ch. 19, 4.9
without a change in status of the investee,
payments by the vendor to the purchaser, Ch. 19, 4.12
Ch. 11, 7.4.2.B
180 Index
Investments in associates and joint ventures —contd
equity accounted investment and indicators of impairment,
application of the equity method —contd
Ch. 20, 12.4.3
loss-making associates/joint ventures, Ch. 11, 7.9
equity accounted investments and long term loans, Ch. 20,
non-coterminous accounting periods, Ch. 11, 7.7
12.4.4
overview, Ch. 11, 7.1
equity accounted investments and CGUs, Ch. 20, 12.4.5
share of the investee, Ch. 11, 7.5
equity accounted investments and testing goodwill for
accounting for potential voting rights, Ch. 11, 7.5.1
impairment, Ch. 20,12.4.6
cumulative preference shares held by parties other than
fair value less costs of disposal (FVLCD), Ch. 20, 12.4.1
the investor, Ch. 11, 7.5.2
value in use (VIU) for, Ch. 20, 12.4.2
several classes of equity, Ch. 11, 7.5.3
Islamic Finance Consultative Group, Ch. 1, 2.9
where the investee is a group, Ch. 11, 7.5.5
Islamic financial institutions (IFIs), Ch. 28, 3.4.1.A
where the reporting entity is a group, Ch. 11, 7.5.4
Japan, IFRS adoption in, Ch. 1, 4.4.2
transactions between the reporting entity and its
associates/joint ventures, Ch. 11, 7.6
Joint arrangements, Ch. 12, 1–9. See also IFRS 11; Joint control;
contributions of non-monetary assets to an
Joint operations
associate/joint venture, Ch. 11, 7.6.5
accounting for joint operations, Ch. 12, 6
commercial substance, Ch. 11, 7.6.5.A
accounting for rights and obligations, Ch. 12, 6.2
International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards Page 993
